Is Tilray Brands, Inc. (TLRY) a good stock to buy?

Olyth's institutional analysis of TLRY reveals an Altman Z-Score of -4.44 and a Piotroski F-Score of 4/9. These metrics, combined with its 5-year revenue trend ($1.13B most recent), help investors decide if TLRY fits their risk profile.

What is the current P/E ratio for TLRY?

As of the latest trading session, Tilray Brands, Inc. (TLRY) has a trailing P/E ratio of -0.40.

Who is the CEO of Tilray Brands, Inc.?

The current Chief Executive Officer of Tilray Brands, Inc. is Irwin David Simon.

What was TLRY's revenue for the last 5 years?

According to its latest income statements, Tilray Brands, Inc. reported annual revenues of $1.13B (2025), $1.07B (2024), $0.84B (2023), $0.79B (2022), $0.62B (2021) respectively.

Does TLRY pay a dividend?

Tilray Brands, Inc. does not currently pay a dividend to its shareholders.

How much debt and cash flow does TLRY have?

In its latest reporting period, Tilray Brands, Inc. generated $-0.17B in Free Cash Flow against a total debt load of $0.45B.

What is the Price-to-Book (P/B) ratio of Tilray Brands, Inc.?

The Price-to-Book (P/B) ratio for Tilray Brands, Inc. (TLRY) is currently 0.47.

What is the Price-to-Sales (P/S) ratio of TLRY?

Based on trailing twelve-month data, Tilray Brands, Inc. (TLRY) trades at a Price-to-Sales (P/S) ratio of 0.68.

What is Tilray Brands, Inc.'s Return on Equity (ROE)?

Tilray Brands, Inc. (TLRY) has a Return on Equity (ROE) of -92.34%, representing its profitability relative to shareholder equity.

TLRY

Tilray Brands, Inc. · Healthcare

6.46

3.00%(-0.20)

6.62

2.48%(+0.16)

After Hours

Last Updated: — ET

52W L: $3.5052W H: $23.20

$6.61

CHG-0.42 (-5.97%)

H$7.50

L$5.89

VOL55M

TLRY (1h)

Company Profile

Tilray Brands, Inc. engages in the research, cultivation, production, marketing, and distribution of medical cannabis products in Canada, the United States, Europe, Australia, New Zealand, Latin America, and internationally. The company operates through four segments: Cannabis Business, Distribution Business, Beverage Alcohol Business, and Wellness Business. It offers medical and adult-use cannabis products, including GMP-certified flowers, oils, vapes, edibles, and topicals; purchases and resells pharmaceutical and wellness products; and produces, markets, sells, and distributes beverage alcohol products, and hemp-based food and other wellness products. The company offers its products under the Tilray, Aphria, Broken Coast, Symbios, B!NGO, The Batch, P'tite Pof, Dubon, Good Supply, Solei, Chowie Wowie, Canaca, RIFF, SweetWater, Breckenridge Distillery, Alpine Beer Company, and Green Flash brands. It sells its products to retailers, wholesalers, patients, physicians, hospitals, pharmacies, researchers, and governments, as well as direct to consumers. The company was formerly known as Tilray, Inc. Tilray Brands, Inc. is headquartered in Leamington, Canada.

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Employees

2,650

IPO Date

2018-07-19

Beta

2.09

Websitewww.tilray.com↗

TLRY

Breckenridge Distillery Introduces Honey Whiskey Crafted with Rare Nigerian Goldswarm Honey—A Must-Try for Whiskey Enthusiasts

Why Tilray Brands Investors Shouldn't Expect the Company to Post a Profit Anytime Soon

Tilray Brands Q3 Earnings Call Highlights

Tilray Brands Is Looking Better

Tilray Brands' strong cannabis sales and upbeat outlook keeps Jefferies analysts bullish

Tilray Brands’ strong cannabis sales and upbeat outlook keeps Jefferies analysts bullish